4//SEC Filing
Hippel James 4
Accession 0001062993-25-014709
CIK 0000842023other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:38 PM ET
Size
29.3 KB
Accession
0001062993-25-014709
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Hippel James
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-08-15−4,010→ 8,021 total→ Common Stock (4,010 underlying) - Tax Payment
Common Stock
2025-08-15$53.60/sh−1,926$103,234→ 129,883 total - Award
Performance Restricted Stock Units
2025-08-15+29,420→ 29,420 total→ Common Stock (29,420 underlying) - Award
Stock Options (Right to Buy)
2025-08-15+37,632→ 37,632 totalExercise: $53.60Exp: 2035-08-15→ Common Stock (37,632 underlying) - Exercise/Conversion
Common Stock
2025-08-15+4,010→ 131,809 total - Award
Restricted Stock Units
2025-08-15+14,710→ 14,710 total→ Common Stock (14,710 underlying)
Holdings
- 167,328
Stock Options (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (167,328 underlying) - 45,220
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (45,220 underlying) - 37,314
Performance Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (37,314 underlying) - 32,417
Stock Options (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (32,417 underlying) - 13,159
Restricted Stock Units
→ Common Stock (13,159 underlying) - 34,634
Restricted Stock Units
→ Common Stock (34,634 underlying) - 186,068
Stock Options (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (186,068 underlying) - 13,865
Performance Restricted Stock Units
→ Common Stock (13,865 underlying) - 24,062
Performance Restricted Stock Units
→ Common Stock (24,062 underlying) - 40,536
Stock Options (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (40,536 underlying) - 45,923
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (45,923 underlying)
Footnotes (13)
- [F1]Fully exercisable.
- [F10]11,545 restricted stock units vest on each of 11/1/2025 and 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.
- [F11]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F12]4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.
- [F13]Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- [F3]Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
- [F4]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F5]Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
- [F6]13,159 restricted stock units vest on 11/1/2025.
- [F7]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F8]4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027.
- [F9]Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001603594
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:38 PM ET
- Size
- 29.3 KB